Evaluation of intra- and transretinal blood flow in Retinal Angiomatous Proliferation detected with phase-resolved Optical Coherence Tomography before and after treatment

Completed

• Conditions: RAP; 10047060

• Registration Number: NL-OMON45004
• Lead Sponsor: Oogziekenhuis Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

Age * 60 years
Diagnosis of RAP based on fundus photography, FA and/or ICG
The study eye has not been treated for exudative ARMD for at least one year (i.e. no treatment with anti-VEGF, periocular steroids or laser in the study eye within the last year). The specific RAP location has to be treatment-naïve for laser
Informed consent

Exclusion Criteria

Ocular surgery within the last 3 months, with the exception of uncomplicated cataract surgery.
Participation in another ophthalmic trial requiring follow-up examinations or using an investigational drug within the last 12 weeks
Other active ocular diseases which irreversibly compromise or, during follow-up, are likely to compromise visual acuity or good visualization of the study eye including ocular surgery scheduled within 3 months after start of the study

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Structural changes and intra-/transretinal blood flow.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>visual acuity<br /><br>fundusphotography<br /><br>FA/ICG<br /><br>SD-OCT</p><br>